Biktarvy, formally known as bictegravir, is a potent single-tablet regimen for treating HIV infection. This formula combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the virus's ability to multiply within the body, considerably decreasing the viral burden. For many individual